An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
NCT00002266
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
AS-101
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer